IL-1 beta/IL-1F2 Antibody (1027B) [Alexa Fluor® 405] Summary
Additional Information |
Recombinant Monoclonal Antibody |
Immunogen |
E.coli-derived recombinant human IL‑1 beta /IL‑1F2 Ala117-Ser269 Accession # P01584 |
Specificity |
Detects human IL‑1 beta /IL‑1F2 in direct ELISAs. |
Source |
N/A |
Isotype |
IgG |
Clonality |
Monoclonal |
Host |
Rabbit |
Purity Statement |
Protein A or G purified from cell culture supernatant |
Innovator's Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase. |
Applications/Dilutions
Dilutions |
- Intracellular Staining by Flow Cytometry 0.25-1 ug/10^6 cells
|
Packaging, Storage & Formulations
Storage |
Protect from light. Do not freeze.- 12 months from date of receipt, 2 to 8 °C as supplied.
|
Buffer |
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide. |
Notes
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for IL-1 beta/IL-1F2 Antibody (1027B) [Alexa Fluor® 405]
Background
IL-1 is a name that designates two pleiotropic cytokines,
IL-1 alpha (IL-1F1) and IL-1 beta (IL-1F2, IL1B), which are the products of distinct
genes. IL-1 alpha and IL-1 beta are structurally related polypeptides that share
approximately 21% amino acid (aa) identity in human. Both proteins are produced
by a wide variety of cells in response to inflammatory agents, infections, or
microbial endotoxins. While IL-1 alpha and IL-1 beta are regulated independently, they
bind to the same receptor and exert identical biological effects. IL-1 RI binds
directly to IL-1 alpha or IL-1 beta and then associates with IL-1 R accessory protein
(IL-1 R3/IL-1 R AcP) to form a high-affinity receptor complex that is competent
for signal transduction. IL-1 RII has high affinity for IL-1 beta but functions as
a decoy receptor and negative regulator of IL-1 beta activity. IL-1ra functions as
a competitive antagonist by preventing IL-1 alpha and IL-1 beta from interacting with
IL-1 RI. Intracellular cleavage of the IL-1 beta precursor by Caspase-1/ICE is
a key step in the inflammatory response. The 17 kDa molecular weight mature
human IL-1 beta shares 96% aa sequence identity with rhesus and 67%-78% with
canine, cotton rat, equine, feline, mouse, porcine, and rat IL-1 beta . IL-1 beta functions
in a central role in immune and inflammatory responses, bone remodeling, fever,
carbohydrate metabolism, and GH/IGF-I physiology. IL-1 beta dysregulation is
implicated in many pathological conditions including sepsis, rheumatoid
arthritis, inflammatory bowel disease, acute and chronic myelogenous leukemia,
insulin-dependent diabetes mellitus, atherosclerosis, neuronal injury, and
aging-related diseases.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are
guaranteed for 1 year from date of receipt.
Customers Who Viewed This Item Also Viewed...
Species: Hu
Applications: BA
Species: Mu
Applications: ELISA
Species: Hu
Applications: BA
Species: Hu
Applications: ELISA
Species: Hu
Applications: BA
Species: Mu
Applications: ELISA
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Hu
Applications: CyTOF-ready, ELISA(Cap), ELISA(Det), ELISA(Sta), ICC, ICFlow, Neut, Simple Western, WB
Species: Hu
Applications: BA
Species: Hu, Mu, Po, Rt
Applications: Flow, IB, ICC/IF, IHC, IHC-Fr, IHC-P, In vitro, WB
Species: Hu
Applications: BA
Species: Hu
Applications: BA
Species: Hu, Rb, Rt
Applications: Flow, IHC, IHC-P, KO, Simple Western, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
Species: Hu
Applications: ELISA
Species: Mu
Applications: AdBlk, IHC, WB
Species: Hu
Applications: Flow
Publications for IL-1 beta/IL-1F2 Antibody (IC8406V) (0)
There are no publications for IL-1 beta/IL-1F2 Antibody (IC8406V).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for IL-1 beta/IL-1F2 Antibody (IC8406V) (0)
There are no reviews for IL-1 beta/IL-1F2 Antibody (IC8406V).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
FAQs for IL-1 beta/IL-1F2 Antibody (IC8406V) (0)